Sleep disorders are commonly seen in different medical disease statuses, giving undesirable consequences for patients’ quality of life. Sleep disorders also make patients’ comorbidities more severe and uncontrolled due to their harmful impact on health conditions and patients’ neuro-psychology. Thus, a strategic approach to the diagnosis and treatment of sleep disorders in medical pathologies is important and necessary. Among these medical pathologies, there is a close relationship between sleep disorders and airway diseases. Airway diseases such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, lung fibrosis, or even Covid-19 and post-Covid may disturb sleep architecture, reduce sleep quality, and induce refractory insomnia or symptomatic obstructive sleep apnea (OSA). These bi-directional consequences have a malefic influence on patients’ neuro-psychological status, quality of life, and healthcare burden.
The current Research Topic aims to illustrate the causal relationship between sleep disorders and airway diseases and their burden on patients’ health. The analysis of the link between both diseases may help to establish appropriate diagnostic and therapeutic approaches for controlling patients’ co-morbidities and ultimately improve patients’ outcomes and wellbeing.
Thus, the goal of this Research Topic is to provide a state-of-the-art assessment of the main characteristics of sleep disorders in acute or chronic airways diseases, including insomnia, sleep apnea, circadian rhythm disturbance, and respiratory disorders during sleep. Particularly, we welcome research involving the most recent advances in diagnostic biomarkers, advanced imagery, polysomnography and diagnostic tools using artificial intelligence.
We invite researchers to submit a range of articles, including but not limited to, original research articles, reviews, opinions, perspectives, and case reports on the following topics:
• Sleep disorders in allergic rhinitis
• Obstructive sleep apnea (OSA) in allergic rhinitis
• Sleep disorder in asthma
• Sleep disorder in COPD
• Sleep disorder in cystic fibrosis
• OSA in obstructive lung disease (OLDOSA)
• OSA in asthma or COPD
• OSA in lung fibrosis
• Insomnia in upper and lower airway diseases
• Sleep disorder in airway neoplasia/cancer
• Sleep disorder in Covid-19 and post-Covid.
Conflicts of interest disclosure: Prof Timothy Craig has received Research funding (R), Consultancy fees (C) Speaking Fees (S) and Travel fees (T) from the following: CSL Behring (R,C,S,T), Grifols (R,S,T), Takeda (R,S,T), Biocryst (R,T), Pharming (S,T), Regeneron (R,C,S), Astra-Zeneca (C) and Kalvista (R).
Sleep disorders are commonly seen in different medical disease statuses, giving undesirable consequences for patients’ quality of life. Sleep disorders also make patients’ comorbidities more severe and uncontrolled due to their harmful impact on health conditions and patients’ neuro-psychology. Thus, a strategic approach to the diagnosis and treatment of sleep disorders in medical pathologies is important and necessary. Among these medical pathologies, there is a close relationship between sleep disorders and airway diseases. Airway diseases such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, lung fibrosis, or even Covid-19 and post-Covid may disturb sleep architecture, reduce sleep quality, and induce refractory insomnia or symptomatic obstructive sleep apnea (OSA). These bi-directional consequences have a malefic influence on patients’ neuro-psychological status, quality of life, and healthcare burden.
The current Research Topic aims to illustrate the causal relationship between sleep disorders and airway diseases and their burden on patients’ health. The analysis of the link between both diseases may help to establish appropriate diagnostic and therapeutic approaches for controlling patients’ co-morbidities and ultimately improve patients’ outcomes and wellbeing.
Thus, the goal of this Research Topic is to provide a state-of-the-art assessment of the main characteristics of sleep disorders in acute or chronic airways diseases, including insomnia, sleep apnea, circadian rhythm disturbance, and respiratory disorders during sleep. Particularly, we welcome research involving the most recent advances in diagnostic biomarkers, advanced imagery, polysomnography and diagnostic tools using artificial intelligence.
We invite researchers to submit a range of articles, including but not limited to, original research articles, reviews, opinions, perspectives, and case reports on the following topics:
• Sleep disorders in allergic rhinitis
• Obstructive sleep apnea (OSA) in allergic rhinitis
• Sleep disorder in asthma
• Sleep disorder in COPD
• Sleep disorder in cystic fibrosis
• OSA in obstructive lung disease (OLDOSA)
• OSA in asthma or COPD
• OSA in lung fibrosis
• Insomnia in upper and lower airway diseases
• Sleep disorder in airway neoplasia/cancer
• Sleep disorder in Covid-19 and post-Covid.
Conflicts of interest disclosure: Prof Timothy Craig has received Research funding (R), Consultancy fees (C) Speaking Fees (S) and Travel fees (T) from the following: CSL Behring (R,C,S,T), Grifols (R,S,T), Takeda (R,S,T), Biocryst (R,T), Pharming (S,T), Regeneron (R,C,S), Astra-Zeneca (C) and Kalvista (R).